Abstract:
:A computational approach for molecular design, PRO_LIGAND, has been developed within the PROMETHEUS molecular design and simulation system in order to provide a unified framework for the de novo generation of diverse molecules which are either similar or complementary to a specified target. In this instance, the target is a pharmacophore derived from a series of active structures either by a novel interpretation of molecular field analysis data or by a pharmacophore-mapping procedure based on clique detection. After a brief introduction to PRO_LIGAND, a detailed description is given of the two pharmacophore generation procedures and their abilities are demonstrated by the elucidation of pharmacophores for steroid binding and ACE inhibition, respectively. As a further indication of its efficacy in aiding the rational drug design process, PRO_LIGAND is then employed to build novel organic molecules to satisfy the physicochemical constraints implied by the pharmacophores.
journal_name
J Med Chemjournal_title
Journal of medicinal chemistryauthors
Waszkowycz B,Clark DE,Frenkel D,Li J,Murray CW,Robson B,Westhead DRdoi
10.1021/jm00049a019subject
Has Abstractpub_date
1994-11-11 00:00:00pages
3994-4002issue
23eissn
0022-2623issn
1520-4804journal_volume
37pub_type
杂志文章abstract::Malaria is still a leading cause of mortality among children in the developing world, and despite the immense progress made in reducing the global burden, further efforts are needed if eradication is to be achieved. In this context, targeting transmission is widely recognized as a necessary intervention toward that go...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.9b00898
更新日期:2020-03-12 00:00:00
abstract::The protein kinase C (PKC) family of serine/threonine kinases is implicated in a wide variety of cellular processes. The PKC theta (PKCtheta) isoform is involved in TCR signal transduction and T cell activation and regulates T cell mediated diseases, including lung inflammation and airway hyperresponsiveness. Thus inh...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm800214a
更新日期:2008-10-09 00:00:00
abstract::Several new 1-substituted 3,5-dimethylpyrazoles were prepared for testing as hypoglycemic agents. A number of these containing para-substituted 1-carbonylphenylurea and para-substituted 1-carbamoylbenzenesulfonylurea derivatives were found to possess potent hypoglycemic activity. ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00365a023
更新日期:1983-11-01 00:00:00
abstract::We have identified 5-(3-chlorothiophen-2-yl)-3-(4-trifluoromethylphenyl)-1,2,4-oxadiazole (1d) as a novel apoptosis inducer through our caspase- and cell-based high-throughput screening assay. Compound 1d has good activity against several breast and colorectal cancer cell lines but is inactive against several other ca...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm050292k
更新日期:2005-08-11 00:00:00
abstract::The discovery of the (acryloylaryloxy)acetic acids as a new class of potent diuretics prompted the investigation of related bicyclic compounds. Annelated analogues of the parent series, the (2-alkyl- and 2,2-dialkyl-1-oxo-5-indanyloxy)acetic acids, were the subjects of this study. Those compounds, unlike the monocycli...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00221a010
更新日期:1977-11-01 00:00:00
abstract::The relative simplicity and high specificity of peptide therapeutics has fueled recent interest. However, peptide and protein drugs generally require injection and suffer from low metabolic stability. We report here the design, synthesis, and characterization of fluorinated analogues of the gut hormone peptide, GLP-1....
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm8008579
更新日期:2008-11-27 00:00:00
abstract::A comprehensive herbal medicine information system for cancer (CHMIS-C) has been developed. The current version of the database integrates information on more than 200 anticancer herbal recipes that have been used for the treatment of different types of cancer in clinic, 900 individual ingredients, and 8500 small orga...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm049838d
更新日期:2005-03-10 00:00:00
abstract::Class A-class C mechanism-based beta-lactamase inhibitors were designed on the basis of the intermediacy of an oxycarbenium species capable of cross-linking with amino acids residues in the active site. Penams 24 and 27 were very potent against AmpC in vitro. The MIC values of 24 in combination with piperacillin again...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm034056q
更新日期:2003-06-19 00:00:00
abstract::The fumagillin family of natural products inhibits angiogenesis through the irreversible inhibition of the type 2 methionine aminopeptidase (MetAP2). Herein is reported a novel fumagillin analogue named fumarranol. It is shown that, like fumagillin, fumarranol selectively inhibits MetAP2 and endothelial cell prolifera...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm060559v
更新日期:2006-09-21 00:00:00
abstract::Therapies based on activation of multiple Toll-like receptors (TLRs) may offer superior therapeutic profiles than that of single TLR activation. To discover new small molecules that could activate multiple TLRs, we performed a cell-based high-throughput screening of a small-molecule library based on TLR3-mediated NF-κ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.7b00419
更新日期:2017-06-22 00:00:00
abstract::New 5'-O-carbonate prodrugs of zidovudine (AZT) have been synthesized in order to enhance its uptake by HIV-1 infected cells, to improve its anti-HIV potency, and to optimize the intramolecular cyclic rearrangement process related to the 5'-O-(4-hydroxybutyl) carbonate moiety. Evidence of this prodrug rearrangement wa...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm010863i
更新日期:2001-08-30 00:00:00
abstract::Membrane-bound aminopeptidase P (AP-P) participates in the degradation of bradykinin in several vascular beds. We have developed an inhibitor of AP-P called apstatin (1) (N-[(2S, 3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]-L-prolyl-L-prolyl-L-al aninam ide); IC50,human = 2.9 microM. In the rat, apstatin can potentiate th...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9805642
更新日期:1999-07-01 00:00:00
abstract::In a search for improved multiple drug resistance (MDR) modulators, we identified a novel series of substituted pyrroloquinolines that selectively inhibits the function of P-glycoprotein (Pgp) without modulating multidrug resistance-related protein 1 (MRP1). These compounds were evaluated for their toxicity toward dru...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0303204
更新日期:2004-03-11 00:00:00
abstract::Nalfurafine, a κ-selective opioid receptor agonist, unexpectedly showed a selective antagonist activity toward the orexin 1 receptor (OX1R) (Ki = 250 nM). Modification of the 17-amino side chain of the opioid ligand to an arylsulfonyl group and the 6-furan acrylamide chain to 2-pyridyl acrylamide led to compound 71 wi...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.6b01418
更新日期:2017-02-09 00:00:00
abstract::A novel cytochrome P450, CYP53A15, was identified in the pathogenic filamentous ascomycete Cochliobolus lunatus. The protein, classified into the CYP53 family, was capable of para hydroxylation of benzoate. Benzoate is a key intermediate in the metabolism of aromatic compounds in fungi and yet basically toxic to the o...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm800030e
更新日期:2008-06-26 00:00:00
abstract::Thirteen newly synthesized or resynthesized diamine-platinum(II) complexes were characterized, and their cytotoxic activities (IC50) were tested on parental and resistant ovarian cancer cell lines. They represent models of conjugates between biologically active vectors and cytotoxic Pt(II) moieties within the "drug ta...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm049508t
更新日期:2005-02-10 00:00:00
abstract::Nintedanib (BIBF1120) is a potent, oral, small-molecule tyrosine kinase inhibitor, also known as a triple angiokinase inhibitor, inhibiting three major signaling pathways involved in angiogenesis. Nintedanib targets proangiogenic and pro-fibrotic pathways mediated by the VEGFR family, the fibroblast growth factor rece...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章,评审
doi:10.1021/jm501562a
更新日期:2015-02-12 00:00:00
abstract::Quantitative structure-activity relationships (QSAR) have been established for the inhibition of dihydrofolate reductase and thymidylate synthetase by 2,4-diaminoquinazoline-glutamic acid analogues. For dihydrofolate reductase from both human acute lymphocytic leukemia cells and murine L1210R cells, QSAR's obtained wi...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00191a005
更新日期:1979-05-01 00:00:00
abstract::The cannabinoid type 2 (CB2) receptor has emerged as a valuable target for therapy and imaging of immune-mediated pathologies. With the aim to find a suitable radiofluorinated analogue of the previously reported CB2 positron emission tomography (PET) radioligand [11C]RSR-056, 38 fluorinated derivatives were synthesize...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.9b01280
更新日期:2019-12-26 00:00:00
abstract::This report describes the syntheses and structure-activity relationships of 8-(4-methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) receptor antagonists. CRF(1) receptor antagonists may be potential anxiolytic or antidepressant drugs. This research culminated in the discove...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9000242
更新日期:2009-05-14 00:00:00
abstract::The conformation of the sodium salt of mycophenolic acid (MPA), a potent inhibitor of inosine monophosphate dehydrogenase (IMPD), derived from 1D DIFNOE and 2D ROESY experiments in water and molecular dynamics (MD) is described. The hexenoic acid side chain conformation consistent with the NMR data was similar to that...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm950600m
更新日期:1996-03-15 00:00:00
abstract::We describe here the design, synthesis, molecular modeling, and biological evaluation of a series of small molecule, nonpeptide inhibitors of SARS-CoV PLpro. Our initial lead compound was identified via high-throughput screening of a diverse chemical library. We subsequently carried out structure-activity relationship...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm900611t
更新日期:2009-08-27 00:00:00
abstract::The JmjC oxygenases catalyze the N-demethylation of N(ε)-methyl lysine residues in histones and are current therapeutic targets. A set of human 2-oxoglutarate analogues were screened using a unified assay platform for JmjC demethylases and related oxygenases. Results led to the finding that daminozide (N-(dimethylamin...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm300677j
更新日期:2012-07-26 00:00:00
abstract::The diphtheria toxin-like ADP-ribosyltransferases (ARTDs) are an enzyme family that catalyzes the transfer of ADP-ribose units onto substrate proteins by using nicotinamide adenine dinucleotide (NAD(+)) as a cosubstrate. They have a documented role in chromatin remodelling and DNA repair, and inhibitors of ARTD1 and 2...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm300746d
更新日期:2012-09-13 00:00:00
abstract::Para-substituted analogues of the antimuscarinic agent caramiphen were synthesized and evaluated for their ability to bind to the M1 and M2 subtypes of the muscarinic receptor. The purpose of the set was to look for a possible relationship in binding affinity or receptor subtype selectivity with aromatic substituent p...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00114a005
更新日期:1991-10-01 00:00:00
abstract::We report the synthesis and antiviral activity of a new family of non-nucleoside antivirals, derived from the 4-keto-1,2-oxathiole-2,2-dioxide (beta-keto-gamma-sultone) heterocyclic system. Several 4- and 5-substituted-5H-1,2-oxathiole-2,2-dioxide derivatives were found to have a selective inhibitory activity against ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm8014662
更新日期:2009-03-26 00:00:00
abstract::Melanin concentrating hormone (MCH) is involved in regulation of food intake and energy homeostasis. Antagonists of the MCH receptor are expected to affect food intake and weight gain, making MCH-R1 an attractive target for obesity treatment. Herein, we report the discovery of a novel, orally active series of MCH-R1 a...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm049035q
更新日期:2005-04-07 00:00:00
abstract::As part of an ongoing effort to discover novel small-molecule antifolates combining the enzyme-binding species selectivity of trimethoprim (TMP) with the potency of piritrexim (PTX), 10 previously unreported 2,4-diamino-5-(2'-methoxy-5'-substituted)benzylpyrimidines (2-11) containing a carboxyl group at the distal end...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm020466n
更新日期:2003-04-24 00:00:00
abstract::The N-arginyl derivative of methionine-enkephalin (fragment 60-65 of beta-lipotropin) has been shown to be equiactive with the parent pentapeptide, despite the fact that the tyrosine amino group in this compound has been neutralized by the formation of an amide linkage. A series of N-(amino acid) derivatives of (-)-5,...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00143a007
更新日期:1981-11-01 00:00:00
abstract::Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin and leptin receptor pathways and thus an attractive therapeutic target for diabetes and obesity. Starting with a high micromolar lead compound, structure-based optimization of novel PTP1B inhibitors by extension of the molecule from the enz...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0702478
更新日期:2007-09-20 00:00:00